b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">31694116</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>15</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>08</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">0376-2491</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>99</Volume>\n                    <Issue>41</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                        <Day>05</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Zhonghua yi xue za zhi</Title>\n                <ISOAbbreviation>Zhonghua Yi Xue Za Zhi</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Distribution characteristics and correlation analysis of antibody detection value in myasthenia gravis].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>3221-3226</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0376-2491.2019.41.005</ELocationID>\n            <Abstract>\n                <AbstractText><b>Objective:</b> To determine the factors affecting distribution and magnitude of antibody detection value in myasthenia gravis (MG). <b>Methods:</b> A total of 406 MG patients diagnosed at Department of Neurology, Peking University First Hospital from May 2015 to November 2017 were included.All of them exhibited muscle fatigue with decreased response in repetitive nerve stimulation test. There were 200 males and 206 females whose ages ranged from 2 to 85 years old. According to clinical classification of MG recommended by Myasthenia Gravis Foundation of America (MGFA), patients assigned to class I to class V included 200,140, 46, 15 and 5 cases, respectively. There were 33 cases of thymic hyperplasia and 63 cases of thymoma confirmed by radiological or pathological findings. Quantile plots and quantile regression model were used to determine the effects of age, gender and MGFA classification, thymus disease on acetylcholine receptors (AChR)antibody, acetylcholinesterase (AChE) antibody, Titin antibody, ryanodine receptor (RyR) antibody and muscle-specific tyrosine kinase (MuSK) antibody detection values detected by enzyme-linked immunosorbent assay (ELISA). <b>Results:</b> MGFA classification had effects on distribution of AChR antibody level. There was a positive correlation between age and AChR antibody level(<i>P&lt;</i>0.05). Negative correlation was found between age and AChE, Titin and RyR antibody level (<i>P&lt;</i>0.05). No significant correlation was shown between any factors and MuSK antibody level(<i>P</i>\xe2\x89\xa50.05). MGFA classification had a positive correlation with AChR antibody level (<i>P&lt;</i>0.05) and no correlation with other antibody levels (<i>P&gt;</i>0.05). Gender and thymus disease had no correlation with any tested antibody levels (<i>P&gt;</i>0.05). <b>Conclusion:</b> MGFA classification has significant effects on distribution of AChR antibody level. Age and MGFA classification have positive correlation with AChR antibody level.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Liu</LastName>\n                    <ForeName>Y L</ForeName>\n                    <Initials>YL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, Peking University First Hospital, Beijing100034, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zheng</LastName>\n                    <ForeName>Y M</ForeName>\n                    <Initials>YM</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Luo</LastName>\n                    <ForeName>J J</ForeName>\n                    <Initials>JJ</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>W</ForeName>\n                    <Initials>W</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gao</LastName>\n                    <ForeName>F</ForeName>\n                    <Initials>F</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yuan</LastName>\n                    <ForeName>Y</ForeName>\n                    <Initials>Y</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hao</LastName>\n                    <ForeName>H J</ForeName>\n                    <Initials>HJ</Initials>\n                </Author>\n            </AuthorList>\n            <Language>chi</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>2011ZX09307-001-07</GrantID>\n                    <Agency>National Science &amp; Technology Pillar Program during the Twelfth Five-year Plan Period</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>China</Country>\n            <MedlineTA>Zhonghua Yi Xue Za Zhi</MedlineTA>\n            <NlmUniqueID>7511141</NlmUniqueID>\n            <ISSNLinking>0376-2491</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009157" MajorTopicYN="Y">Myasthenia Gravis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013945" MajorTopicYN="Y">Thymoma</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013952" MajorTopicYN="Y">Thymus Hyperplasia</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013953" MajorTopicYN="Y">Thymus Neoplasms</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <OtherAbstract Type="Publisher" Language="chi">\n            <AbstractText><b>\xe7\x9b\xae\xe7\x9a\x84\xef\xbc\x9a</b> \xe6\x8e\xa2\xe8\xae\xa8\xe5\xbd\xb1\xe5\x93\x8d\xe9\x87\x8d\xe7\x97\x87\xe8\x82\x8c\xe6\x97\xa0\xe5\x8a\x9b\xef\xbc\x88MG\xef\xbc\x89\xe4\xb8\x8d\xe5\x90\x8c\xe6\x8a\x97\xe4\xbd\x93\xe6\xb5\x8b\xe5\xae\x9a\xe6\x95\xb0\xe5\x80\xbc\xe5\x88\x86\xe5\xb8\x83\xe7\x89\xb9\xe5\xbe\x81\xe4\xb8\x8e\xe6\x95\xb0\xe5\x80\xbc\xe5\xa4\xa7\xe5\xb0\x8f\xe7\x9a\x84\xe7\x9b\xb8\xe5\x85\xb3\xe5\x9b\xa0\xe7\xb4\xa0\xe3\x80\x82 <b>\xe6\x96\xb9\xe6\xb3\x95\xef\xbc\x9a</b> \xe7\xa0\x94\xe7\xa9\xb6\xe7\xba\xb3\xe5\x85\xa5\xe4\xba\x862015\xe5\xb9\xb45\xe6\x9c\x88\xe8\x87\xb32017\xe5\xb9\xb411\xe6\x9c\x88\xe5\xb0\xb1\xe8\xaf\x8a\xe4\xba\x8e\xe5\x8c\x97\xe4\xba\xac\xe5\xa4\xa7\xe5\xad\xa6\xe7\xac\xac\xe4\xb8\x80\xe5\x8c\xbb\xe9\x99\xa2\xe7\xa5\x9e\xe7\xbb\x8f\xe5\x86\x85\xe7\xa7\x91\xe7\x9a\x84406\xe4\xbe\x8bMG\xe6\x82\xa3\xe8\x80\x85\xe3\x80\x82\xe6\x89\x80\xe6\x9c\x89\xe6\x82\xa3\xe8\x80\x85\xe5\x9d\x87\xe5\x85\xb7\xe6\x9c\x89\xe7\x97\x85\xe7\x90\x86\xe6\x80\xa7\xe8\x82\x8c\xe7\x96\xb2\xe5\x8a\xb3\xe7\x8e\xb0\xe8\xb1\xa1\xef\xbc\x8c\xe4\xbd\x8e\xe9\xa2\x91\xe7\xa5\x9e\xe7\xbb\x8f\xe9\x87\x8d\xe5\xa4\x8d\xe7\x94\xb5\xe5\x88\xba\xe6\xbf\x80\xe5\x87\xba\xe7\x8e\xb0\xe6\xb3\xa2\xe5\xb9\x85\xe9\x80\x92\xe5\x87\x8f\xef\xbc\x8c\xe5\xaf\xb9\xe6\xba\xb4\xe6\xaf\x94\xe6\x96\xaf\xe7\x9a\x84\xe6\x98\x8e\xe6\xb2\xbb\xe7\x96\x97\xe6\x9c\x89\xe6\x95\x88\xe3\x80\x82\xe5\x85\xb6\xe4\xb8\xad\xe7\x94\xb7200\xe4\xbe\x8b\xef\xbc\x8c\xe5\xa5\xb3206\xe4\xbe\x8b\xef\xbc\x8c\xe5\xb9\xb4\xe9\xbe\x842~85\xe5\xb2\x81\xe3\x80\x82\xe7\xbe\x8e\xe5\x9b\xbd\xe9\x87\x8d\xe7\x97\x87\xe8\x82\x8c\xe6\x97\xa0\xe5\x8a\x9b\xe5\x8d\x8f\xe4\xbc\x9a\xef\xbc\x88MGFA\xef\xbc\x89\xe4\xb8\xb4\xe5\xba\x8a\xe5\x88\x86\xe5\x9e\x8b\xe7\x9a\x84\xe2\x85\xa0~\xe2\x85\xa4\xe5\x9e\x8b\xe5\x88\x86\xe5\x88\xab\xe6\x9c\x89200\xe4\xbe\x8b\xe3\x80\x81140\xe4\xbe\x8b\xe3\x80\x8146\xe4\xbe\x8b\xe3\x80\x8115\xe4\xbe\x8b\xe5\x8f\x8a5\xe4\xbe\x8b\xe3\x80\x82\xe5\xbd\xb1\xe5\x83\x8f\xe5\xad\xa6\xe6\x88\x96\xe7\x97\x85\xe7\x90\x86\xe6\xa3\x80\xe6\x9f\xa5\xe8\xaf\x81\xe5\xae\x9e33\xe4\xbe\x8b\xe6\x82\xa3\xe8\x80\x85\xe5\x85\xb7\xe6\x9c\x89\xe8\x83\xb8\xe8\x85\xba\xe5\xa2\x9e\xe7\x94\x9f\xef\xbc\x8c63\xe4\xbe\x8b\xe6\x82\xa3\xe8\x80\x85\xe5\x85\xb7\xe6\x9c\x89\xe8\x83\xb8\xe8\x85\xba\xe7\x98\xa4\xe3\x80\x82\xe4\xbe\x9d\xe6\x8d\xae\xe5\xb9\xb4\xe9\xbe\x84\xe3\x80\x81\xe6\x80\xa7\xe5\x88\xab\xe3\x80\x81MGFA\xe5\x88\x86\xe5\x9e\x8b\xe5\x8f\x8a\xe8\x83\xb8\xe8\x85\xba\xe7\x97\x85\xe5\x8f\x98\xe6\x83\x85\xe5\x86\xb5\xe5\xaf\xb9\xe6\x82\xa3\xe8\x80\x85\xe8\xbf\x9b\xe8\xa1\x8c\xe5\x88\x86\xe7\xbb\x84\xe3\x80\x82\xe5\x88\xa9\xe7\x94\xa8\xe5\x88\x86\xe4\xbd\x8d\xe6\x95\xb0\xe4\xb8\x8e\xe5\x88\x86\xe4\xbd\x8d\xe6\x95\xb0\xe6\x9b\xb2\xe7\xba\xbf\xe5\x88\x86\xe6\x9e\x90\xe4\xb8\x8d\xe5\x90\x8c\xe5\x88\x86\xe7\xbb\x84\xe7\xbb\x8f\xe9\x85\xb6\xe8\x81\x94\xe5\x85\x8d\xe7\x96\xab\xe5\x90\xb8\xe9\x99\x84\xe6\xb5\x8b\xe5\xae\x9a\xef\xbc\x88ELISA\xef\xbc\x89\xe6\x96\xb9\xe6\xb3\x95\xe6\xa3\x80\xe6\xb5\x8b\xe6\x89\x80\xe5\xbe\x97\xe7\x9a\x84\xe4\xb9\x99\xe9\x85\xb0\xe8\x83\x86\xe7\xa2\xb1\xe5\x8f\x97\xe4\xbd\x93\xef\xbc\x88AChR\xef\xbc\x89\xe6\x8a\x97\xe4\xbd\x93\xe3\x80\x81\xe4\xb9\x99\xe9\x85\xb0\xe8\x83\x86\xe7\xa2\xb1\xe9\x85\xaf\xe9\x85\xb6\xef\xbc\x88AChE\xef\xbc\x89\xe6\x8a\x97\xe4\xbd\x93\xe3\x80\x81\xe9\xaa\xa8\xe9\xaa\xbc\xe8\x82\x8c\xe5\x8f\x97\xe4\xbd\x93\xe9\x85\xaa\xe6\xb0\xa8\xe9\x85\xb8\xe6\xbf\x80\xe9\x85\xb6\xef\xbc\x88MuSK\xef\xbc\x89\xe6\x8a\x97\xe4\xbd\x93\xe3\x80\x81\xe8\x82\x8c\xe8\x81\x94\xe8\x9b\x8b\xe7\x99\xbd\xef\xbc\x88Titin\xef\xbc\x89\xe6\x8a\x97\xe4\xbd\x93\xe5\x92\x8c\xe5\x85\xb0\xe5\xb0\xbc\xe7\xa2\xb1\xe5\x8f\x97\xe4\xbd\x93\xef\xbc\x88RyR\xef\xbc\x89\xe6\x8a\x97\xe4\xbd\x93\xe7\x9a\x84\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe5\x88\x86\xe5\xb8\x83\xe7\x89\xb9\xe5\xbe\x81\xe3\x80\x82\xe5\x88\xa9\xe7\x94\xa8\xe5\x88\x86\xe4\xbd\x8d\xe6\x95\xb0\xe5\x9b\x9e\xe5\xbd\x92\xe6\xa8\xa1\xe5\x9e\x8b\xe8\xbf\x9b\xe8\xa1\x8c\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe4\xb8\x8e\xe5\xb9\xb4\xe9\xbe\x84\xe3\x80\x81\xe6\x80\xa7\xe5\x88\xab\xe3\x80\x81MGFA\xe5\x88\x86\xe5\x9e\x8b\xe5\x8f\x8a\xe8\x83\xb8\xe8\x85\xba\xe7\x97\x85\xe5\x8f\x98\xe7\x9a\x84\xe7\x9b\xb8\xe5\x85\xb3\xe6\x80\xa7\xe5\x88\x86\xe6\x9e\x90\xe3\x80\x82 <b>\xe7\xbb\x93\xe6\x9e\x9c\xef\xbc\x9a</b> AChR\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe5\x9c\xa8\xe4\xb8\x8d\xe5\x90\x8cMGFA\xe5\x88\x86\xe5\x9e\x8b\xe4\xb9\x8b\xe9\x97\xb4\xe5\x88\x86\xe5\xb8\x83\xe5\xb7\xae\xe5\xbc\x82\xe6\x9c\x80\xe4\xb8\xba\xe6\x98\x8e\xe6\x98\xbe\xe3\x80\x82\xe5\xb9\xb4\xe9\xbe\x84\xe4\xb8\x8eAChR\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe5\x85\xb7\xe6\x9c\x89\xe6\xad\xa3\xe7\x9b\xb8\xe5\x85\xb3\xef\xbc\x88<i>P&lt;</i>0.05\xef\xbc\x89\xef\xbc\x8c\xe4\xb8\x8eAChE\xe6\x8a\x97\xe4\xbd\x93\xe3\x80\x81Titin\xe6\x8a\x97\xe4\xbd\x93\xe5\x8f\x8aRyR\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe5\x85\xb7\xe6\x9c\x89\xe8\xb4\x9f\xe7\x9b\xb8\xe5\x85\xb3\xef\xbc\x88<i>P&lt;</i>0.05\xef\xbc\x89\xef\xbc\x8c\xe4\xb8\x8eMuSK\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe6\xb2\xa1\xe6\x9c\x89\xe5\x9b\x9e\xe5\xbd\x92\xe7\x9b\xb8\xe5\x85\xb3\xe6\x80\xa7\xef\xbc\x88<i>P</i>\xe2\x89\xa50.05\xef\xbc\x89\xe3\x80\x82MGFA\xe5\x88\x86\xe5\x9e\x8b\xe4\xb8\x8eAChR\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe5\x85\xb7\xe6\x9c\x89\xe6\xad\xa3\xe7\x9b\xb8\xe5\x85\xb3\xef\xbc\x88<i>P&lt;</i>0.05\xef\xbc\x89\xef\xbc\x8c\xe4\xb8\x8e\xe5\x85\xb6\xe4\xbb\x96\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe4\xb8\x8d\xe5\x85\xb7\xe6\x9c\x89\xe5\x9b\x9e\xe5\xbd\x92\xe7\x9b\xb8\xe5\x85\xb3\xe6\x80\xa7\xe3\x80\x82\xe6\x80\xa7\xe5\x88\xab\xe5\x8f\x8a\xe8\x83\xb8\xe8\x85\xba\xe7\x97\x85\xe5\x8f\x98\xe4\xb8\x8e\xe4\xb8\x8a\xe8\xbf\xb0\xe6\x8a\x97\xe4\xbd\x93\xe5\x90\xb8\xe5\x85\x89\xe5\xba\xa6\xef\xbc\x88<i>A</i>\xef\xbc\x89\xe5\x80\xbc\xe9\x83\xbd\xe4\xb8\x8d\xe5\x85\xb7\xe6\x9c\x89\xe5\x9b\x9e\xe5\xbd\x92\xe7\x9b\xb8\xe5\x85\xb3\xe3\x80\x82 <b>\xe7\xbb\x93\xe8\xae\xba\xef\xbc\x9a</b> MGFA\xe5\x88\x86\xe5\x9e\x8b\xe5\xaf\xb9AChR\xe6\x8a\x97\xe4\xbd\x93\xe6\xb5\x8b\xe5\xae\x9a\xe6\x95\xb0\xe5\x80\xbc\xe7\x9a\x84\xe5\x88\x86\xe5\xb8\x83\xe7\x89\xb9\xe5\xbe\x81\xe5\xbd\xb1\xe5\x93\x8d\xe6\x9c\x80\xe4\xb8\xba\xe6\x98\xbe\xe8\x91\x97\xe3\x80\x82\xe5\xb9\xb4\xe9\xbe\x84\xe5\x92\x8cMGFA\xe5\x88\x86\xe5\x9e\x8b\xe4\xb8\x8eAChR\xe6\x8a\x97\xe4\xbd\x93\xe6\xb5\x8b\xe5\xae\x9a\xe6\x95\xb0\xe5\x80\xbc\xe5\x85\xb7\xe6\x9c\x89\xe6\xad\xa3\xe7\x9b\xb8\xe5\x85\xb3\xe3\x80\x82.</AbstractText>\n        </OtherAbstract>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Age factors</Keyword>\n            <Keyword MajorTopicYN="N">Antibody</Keyword>\n            <Keyword MajorTopicYN="N">MGFA classification</Keyword>\n            <Keyword MajorTopicYN="N">Myasthenia gravis</Keyword>\n            <Keyword MajorTopicYN="N">Quantile regression analysis</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>16</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31694116</ArticleId>\n            <ArticleId IdType="doi">10.3760/cma.j.issn.0376-2491.2019.41.005</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'